Richard A. Friedman
Richard Alan Friedman, M.D. is professor of Clinical Psychiatry at Weill Cornell Medical College, attending psychiatrist at NewYork–Presbyterian Hospital and director of Psychopharmacology at the Payne Whitney Psychiatric Clinic. He is expert in the pharmacologic treatment of personality, mood and anxiety disorders, obsessive–compulsive disorder, PTSD and refractory depression.
Friedman gained his B.A. in 1978 from Duke University, and his M.D. in 1982 from Robert Wood Johnson Medical School of the University of Medicine and Dentistry of New Jersey. He was associate professor of Clinical Psychiatry at Weill Cornell Medical College from 1996 to 2004.
As of 2014, Friedman's research activity is in the field of chronic depression: evaluating antidepressant medications; studying the effectiveness of long-term treatment; neurobiology; and the social and occupational impairments. He is conducting a clinical study of medication for "double depression" (dysthymia with major depression), and evaluating the role of serotonin in chronic depression. He plans a study simultaneously examining brain activity with MRI, behavior, and serotonin functions in patients with chronic depression.
Friedman is a frequent guest columnist in the Science Times section of The New York Times. Since the spring of 2015, Friedman has been a contributing op-ed writer at The New York Times. In 2011 he contributed to The New York Review of Books.
In 2014 the Financial Times reported that Friedman had been practicing Transcendental Meditation for three years. He was quoted as saying, "I am less reactive to small things that would have bothered and upset me in the past. ... I’m more easy going."
- "Weill Cornell Medical College Faculty". Weill Cornell Medical College. Retrieved 4 August 2014.
- "Richard Alan Friedman, M.D.". Weill Cornell Physicians. Retrieved 4 August 2014.
- "Richard A. Friedman". Vivo. Retrieved 4 August 2014.
- "Mind". New York Times. Retrieved 4 August 2014.
- Wallace, Charles. "Meditate to sharpen your assertive edge". Financial Times. Retrieved 4 August 2014.